Stockreport

Werewolf Therapeutics, Inc. (HOWL) Reports Q2 Loss, Lags Revenue Estimates [Yahoo! Finance]

Werewolf Therapeutics, Inc.  (HOWL) 
PDF This compares to loss of $0.14 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -13.1 [Read more]